Hannah Creta
Psychiatric/Mental Health · Johnston, RINPI 1265040745
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 210 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 24.5% of the total. 2025 is the largest year on record at $2,778, more than ten times the $125 reported in 2021. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 210 payments — averaging $26.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$783
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$706
- Axsome Therapeutics, Inc.$567
- Otsuka America Pharmaceutical, Inc.$546
- Vanda Pharmaceuticals Inc.$470
- plus $1K from 8 others
What the payments were for
- Food & beverage$5,43496%
- Education$2234%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $1,385 |
| Alkermes, Inc. | 31 | $783 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $706 |
| Axsome Therapeutics, Inc. | 19 | $567 |
| Otsuka America Pharmaceutical, Inc. | 21 | $546 |
| Vanda Pharmaceuticals Inc. | 20 | $470 |
| Teva Pharmaceuticals USA, Inc. | 8 | $428 |
| Johnson & Johnson | 7 | $216 |
| Neurocrine Biosciences, Inc. | 10 | $161 |
| Lundbeck LLC | 8 | $161 |
| GSK | 1 | $125 |
| Sage Therapeutics, LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Corium, LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,657 in reported general payments places this provider in the 90th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $476 |
| Clonazepam | 18 | $224 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Johnston
- Patricia GiarrussoJohnston$1K
- Samantha Shawn MarshBradford$639K
- Samuel KaufmanRiverside$19K
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Eniayo EgberongbeCranston$12K
- Deborah HorvitzWarwick$10K
- Donna McDonaldProvidence$9K
- Timothy PepinNorth Smithfield$9K
- Anita ObengCranston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.